Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 70
Number Thumbnail Title Author Date Votes Views
40 Prestige Biopharma IDC Signs Joint Development Agreement with Geovista for Companion Animal Therapeutics
김** | 2025.09.16 | Votes 0 | Views 924
김** 2025.09.16 0 924
39 Prestige Biopharma IDC Selected as a Core Research center in Korea’s ARPA-H Project
김** | 2025.08.20 | Votes 0 | Views 876
김** 2025.08.20 0 876
38 PPrestige Biopharma Secures European Patent for Pancreatic Cancer Antibody PBP1510
김** | 2025.08.01 | Votes 0 | Views 1340
김** 2025.08.01 0 1340
37 Prestige Biopharma IDC Files Patent for Anti-CTHRC1 Antibody Combination Therapy for Solid Tumors
we******** | 2025.07.28 | Votes 0 | Views 796
we******** 2025.07.28 0 796
36 Prestige Biopharma IDC Hosts Regional R&D Engagement Tour with BISTEP and Civic Groups
we******** | 2025.07.16 | Votes 0 | Views 781
we******** 2025.07.16 0 781
35 Prestige Biopharma IDC Shares Antibody-Based Drug Research with KAIST Professors
김** | 2025.07.10 | Votes 0 | Views 878
김** 2025.07.10 0 878
34 Prestige Biopharma Highlights PBP1510 Clinical Progress at ASCO 2025
we******** | 2025.06.04 | Votes 0 | Views 1835
we******** 2025.06.04 0 1835
33 Prestige Biopharma Signs 31 European Licensing and Supply Agreement with Teva for Tuznue®
we******** | 2025.05.26 | Votes 0 | Views 1184
we******** 2025.05.26 0 1184
32 Prestige Biopharma Publishes Preclinical Study of Biosimilar Tuznue® in SCI Journal Drug in R&D
we******** | 2025.04.16 | Votes 0 | Views 882
we******** 2025.04.16 0 882
31 Busan-Jinhae Free Economic Zone Commissioner Visits Prestige Biopharma IDC to Discuss Biopharma Industry Collaboration
we******** | 2025.04.03 | Votes 0 | Views 761
we******** 2025.04.03 0 761

Read Prestige news >>